Home › Trial NCT01259518
Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas
- Trial IDNCT01259518
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorTrin Therapeutics GmbH
- Enrollment48
- Start date2009-11
- ConditionsNeoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.